Skip to main content

Table 2 Graves’ disease as the dichotomized determinant of breast cancer or benign breast tumors

From: TSH receptor antibodies have predictive value for breast cancer – retrospective analysis

Dichotomized determinant Association with BC (n = 9) Association with BBT (n = 47)
χ 2 p χ 2 p
Graves’ disease (n = 120) 9.41 0.0021 2.33 ns
  1. χ2 test of independence analysis of the dichotomized determinant (i.e. Graves’ disease occurrence) of breast cancer (BC) or of benign breast tumors (BBT), performed in all patients; ns, non-significant in all patients.